While we commonly observe TREM2-associated proliferative BCC and BST in human and murine BCCs, the variable abundance of BIT cells in BCC patients and murine tumors argues for a specialized role of the TREM1-associated inflammation in driving high levels of NF-κB signaling in tumor epithelium. The gene discussed is NFKB1; the disease is neoplasm.